Transforming growth factor-β and atherosclerosis: Interwoven atherogenic and atheroprotective aspects

Cell and Tissue Research

Volumn 347, Issue 1, 2012, Pages 155-175

  Toma, Ian ^a   McCaffrey, Timothy A ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Atherosclerosis; Cardiovascular disease; Gene expression; Restenosis; Transforming growth factor

Indexed keywords

MYC PROTEIN; PROTEIN KINASE; PROTEIN P21; RHO FACTOR; SMAD PROTEIN; TRANSCRIPTION FACTOR E2F1; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ARTERY CALCIFICATION; ATHEROGENESIS; ATHEROSCLEROSIS; BINDING AFFINITY; BINDING SITE; BLOOD VESSEL INJURY; BLOOD VESSEL PERMEABILITY; CARDIOVASCULAR INFLAMMATION; CELL DIFFERENTIATION; DIABETES MELLITUS; DISEASE ACTIVITY; DISEASE ASSOCIATION; ENDOTHELIUM CELL; ENZYME ACTIVATION; HEART ANEURYSM; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IMMUNOMODULATION; INTERMETHOD COMPARISON; INTRACARDIAC THROMBOSIS; LYMPHOCYTE PROLIFERATION; MACROPHAGE FUNCTION; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MOLECULAR PATHOLOGY; NONHUMAN; OUTCOME ASSESSMENT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PREVALENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PULMONARY HYPERTENSION; RESTENOSIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; SMOOTH MUSCLE FIBER; VASCULAR SURGERY; VASCULARIZATION;

ANIMALS; ATHEROSCLEROSIS; FIBROSIS; HUMANS; INFLAMMATION; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RISK FACTORS; SMAD PROTEINS; TRANSFORMING GROWTH FACTOR BETA; WOUND HEALING;

EID: 84859440795     PISSN: 0302766X     EISSN: 14320878     Source Type: Journal    
DOI: 10.1007/s00441-011-1189-3     Document Type: Review

References (204)

1. Abe R, Donnelly SC, Peng T, Bucala R, Metz CN (2001) Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol 166:7556-7562 (Pubitemid 32525636)
2. Ahuja SS, Paliogianni F, Yamada H, Balow JE, Boumpas DT (1993) Effect of transforming growth factor-beta on early and late activation events in human T cells. J Immunol 150:3109-3118 (Pubitemid 23129689)
3. Akhurst RJ (2004) TGF[beta] signaling in health and disease. Nat Genet 36:790-792
4. Alexandrow MG, Kawabata M, Aakre M, Moses HL (1995) Over-expression of the c-Myc oncoprotein blocks the growth-inhibitory response but is required for the mitogenic effects of transforming growth factor beta 1. Proc Natl Acad Sci USA 92:3239-3243
5. Andres JL, Stanley K, Cheifetz S, Massague J (1989) Membrane-anchored and soluble forms of betaglycan, a polymorphic proteoglycan that binds transforming growth factor-β. J Cell Biol 109:3137-3145 (Pubitemid 20011937)
6. Assoian RK, Sporn MB (1986) Type β transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells. J Cell Biol 102:1217-1223 (Pubitemid 16038065)
7. August P, Sharma V, Ding R, Schwartz JE, Suthanthiran M (2009) Transforming growth factor beta and excess burden of renal disease. Trans Am Clin Climatol Assoc 120:61-72
8. Bachman KE, Blair BG, Brenner K, Bardelli A, Arena S, Zhou S, Hicks J, De Marzo AM, Argani P, Park BH (2004) p21(WAF1/CIP1) mediates the growth response to TGF-beta in human epithelial cells. Cancer Biol Ther 3:221-225 (Pubitemid 41350908)
9. Battegay EJ, Raines EW, Seifert RA, Bowen-Pope DF, Ross R (1990) TGF-β induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. Cell 63:515-524
10. Belizna CC, Richard V, Primard E, Kerleau JM, Cailleux N, Louvel JP, Marie I, Hamidou M, Thuillez C, Levesque H (2008) Early atheroma in primary and secondary antiphospholipid syndrome: an intrinsic finding. Semin Arthritis Rheum 37:373-380 (Pubitemid 351734519)
11. Bell JA, Bell L (1989) Effect of platelet factors on migration of cultured bovine aortic endothelial and smooth muscle cells. Circ Res 65:1057-1065
12. Bennett MR, Littlewood TD, Schwartz SM, Weissberg PL (1997) Increased sensitivity of human vascular smooth muscle cells from atherosclerotic plaques to p53-mediated apoptosis. Circ Res 81:591-599 (Pubitemid 27432747)
13. Bhowmick NA, Ghiassi M, Aakre M, Brown K, Singh V, Moses HL (2003) TGF-beta-induced RhoA and p160ROCK activation is involved in the inhibition of Cdc25A with resultant cell-cycle arrest. Proc Natl Acad Sci USA 100:15548-15553
14. Bjorkerud S (1991) Effects of transforming growth factor-b1 on human arterial smooth muscle cells in vitro. Arteriosclerosis 11:892-902
15. Bobik A (2006) Transforming growth factor-betas and vascular disorders. Arterioscler Thromb Vasc Biol 26:1712-1720
16. Bobik A, Agrotis A, Kanellakis P, Dilley R, Krushinsky A, Smirnov V, Tararak E, Condron M, Kostolias G (1999) Distinct patterns of transforming growth factor-beta isoform and receptor expression in human atherosclerotic lesions. Colocalization implicates TGF-beta in fibrofatty lesion development. Circulation 99:2883-2891
17. Bochaton-Piallat M-L, Gabbiani F, Ropraz P, Gabbiani G (1993) Age influences the replicative activity and the differentiation features of cultured rat aortic smooth muscle cell populations and clones. Arteriocler Thromb Vasc Biol 13:1449-1455 (Pubitemid 23303397)
18. Bochaton-Piallat ML, Gabbiani F, Redard M, Desmouliere A, Gabbiani G (1995) Apoptosis participates in cellularity regulation during rat aortic intimal thickening. Am J Pathol 146:1059-1064
19. Bonecini-Almeida MG, Ho JL, Boechat N, Huard RC, Chitale S, Doo H, Geng J, Rego L, Lazzarini LC, Kritski AL, Johnson WD Jr, McCaffrey TA, Silva JR (2004) Down-modulation of lung immune responses by interleukin-10 and transforming growth factor beta (TGF-beta) and analysis of TGF-beta receptors I and II in active tuberculosis. Infect Immun 72:2628-2634
20. Borrelli V, Marzo L di, Sapienza P, Colasanti M, Moroni E, Cavallaro A (2006) Role of platelet-derived growth factor and transforming growth factor beta1 in the regulation of metalloproteinase expressions. Surgery 140:454-463
21. Boyd FT, Cheifetz S, Andres J, Laiho M, Massague J (1990) Transforming growth factor-b receptors and binding proteoglycans. J Cell Sci Suppl 13:131-138
22. Bray PJ, Du B, Mejia VM, Hao SC, Deutsch E, Fu C, Wilson RC, Hanauske-Abel H, McCaffrey TA (1999) Glucocorticoid resistance caused by reduced expression of the glucocorticoid receptor in cells from human vascular lesions. Arterioscler Thromb Vasc Biol 19:1180-1189 (Pubitemid 29227636)
23. Brizzi MF, Dentelli P, Rosso A, Calvi C, Gambino R, Cassader M, Salvidio G, Deferrari G, Camussi G, Pegoraro L, Pagano G, Cavallo-Perin P (2004) RAGE- and TGF-beta receptor-mediated signals converge on STAT5 and p21waf to control cell-cycle progression of mesangial cells: a possible role in the development and progression of diabetic nephropathy. FASEB J 18:1249-1251 (Pubitemid 39561566)
24. Buday A, Orsy P, Godo M, Mozes M, Kokeny G, Lacza Z, Koller A, Ungvari Z, Gross ML, Benyo Z, Hamar P (2010) Elevated systemic TGF-beta impairs aortic vasomotor function through activation of NADPH oxidase-driven superoxide production and leads to hypertension, myocardial remodeling, and increased plaque formation in apoE(-/-) mice. Am J Physiol Heart Circ Physiol 299:H386-H395
25. Buoro S, Ferrarese P, Chiavegato A, Roelofs M, Scatena M, Pauletto P, Passerini-Glazel G, Pagano F, Sartore S (1993) Myofibroblast-derived smooth muscle cells during remodelling of rabbit urinary bladder wall induced by partial outflow obstruction. Lab Invest 69:589-602 (Pubitemid 24004496)
26. Burch ML, Ballinger ML, Yang SN, Getachew R, Itman C, Loveland K, Osman N, Little PJ (2010) Thrombin stimulation of proteoglycan synthesis in vascular smooth muscle is mediated by protease-activated receptor-1 transactivation of the transforming growth factor beta type I receptor. J Biol Chem 285:26798-26805
27. Chaouat A, Coulet F, Favre C, Simonneau G, Weitzenblum E, Soubrier F, Humbert M (2004) Endoglin germline mutation in a patient with hereditary haemorrhagic telangiectasia and dexfenfluramine associated pulmonary arterial hypertension. Thorax 59:446-448 (Pubitemid 38624754)
28. Chen CL, Liu IH, Fliesler SJ, Han X, Huang SS, Huang JS (2007) Cholesterol suppresses cellular TGF-beta responsiveness: implications in atherogenesis. J Cell Sci 120:3509-3521 (Pubitemid 350120944)
29. Chen CL, Huang SS, Huang JS (2008) Cholesterol modulates cellular TGF-beta responsiveness by altering TGF-beta binding to TGF-beta receptors. J Cell Physiol 215:223-233
30. Chen JK, Hoshi H, McKeehan WL (1987) Transforming growth factor type beta specifically stimulates synthesis of proteoglycan in human adult arterial smooth muscle cells. Proc Natl Acad Sci USA 84:5287-5291 (Pubitemid 17119123)
31. Chen W, Chu Y, Zhu D, Yan C, Liu J, Ji K, Gao P (2009) Perivascular gene transfer of dominant-negative N19RhoA attenuates neointimal formation via inhibition of TGF-beta1-Smad2 signaling in rats after carotid artery balloon injury. Biochem Biophys Res Commun 389:217-223
32. Cipollone F, Fazia M, Mincione G, Iezzi A, Pini B, Cuccurullo C, Ucchino S, Spigonardo F, Di Nisio M, Cuccurullo F, Mezzetti A, Porreca E (2004) Increased expression of transforming growth factor-beta1 as a stabilizing factor in human atherosclerotic plaques. Stroke 35:2253-2257 (Pubitemid 39311245)
33. Claassen GF, Hann SR (2000) A role for transcriptional repression of p21CIP1 by c-Myc in overcoming transforming growth factor beta-induced cell-cycle arrest. Proc Natl Acad Sci USA 97:9498-9503 (Pubitemid 30650804)
34. Clark KJ, Cary NR, Grace AA, Metcalfe JC (2001) Microsatellite mutation of type II transforming growth factor-beta receptor is rare in atherosclerotic plaques. Arterioscler Thromb Vasc Biol 21:555-559 (Pubitemid 32323388)
35. Datto MB, Yu Y, Wang XF (1995) Functional analysis of the transforming growth factor beta responsive elements in the WAF1/Cip1/p21 promoter. J Biol Chem 270:28623-28628
36. Ebner R, Chen RH, Shum L, Lawler S, Zioncheck TF, Lee A, Lopez AR, Derynck R (1993) Cloning of a type I TGF-beta receptor and its effect on TGF-beta binding to the type II receptor. Science 260:1344-1348 (Pubitemid 23231981)
37. Edlin RS, Tsai S, Yamanouchi D, Wang C, Liu B, Kent KC (2009) Characterization of primary and restenotic atherosclerotic plaque from the superficial femoral artery: potential role of Smad3 in regulation of SMC proliferation. J Vasc Surg 49:1289-1295
38. Enos WF Jr, Beyer JC, Holmes RH (1955) Pathogenesis of coronary disease in American soldiers killed in Korea. J Am Med Assoc 158:912-914
39. Eriksson M, Brown WT, Gordon LB, Glynn MW, Singer J, Scott L, Erdos MR, Robbins CM, Moses TY, Berglund P, Dutra A, Pak E, Durkin S, Csoka AB, Boehnke M, Glover TW, Collins FS (2003) Recurrent de novo point mutations in lamin A cause Hutchinson- Gilford progeria syndrome. Nature 423:293-298 (Pubitemid 40852699)
40. Evans RA, Tian YC, Steadman R, Phillips AO (2003) TGF-beta1-mediated fibroblast-myofibroblast terminal differentiation - the role of Smad proteins. Exp Cell Res 282:90-100 (Pubitemid 36262031)
41. Fadini GP, Tjwa M (2010) A role for TGF-beta in transforming endothelial progenitor cells into neointimal smooth muscle cells. Atherosclerosis 211:32-35
42. Falcone DJ, McCaffrey TA, Haimovitz-Friedman A, Garcia M (1993a) Transforming growth factor-beta 1 stimulates macrophage urokinase expression and release of matrix-bound basic fibroblast growth factor. J Cell Physiol 155:595-605 (Pubitemid 23167403)
43. Falcone DJ, McCaffrey TA, Haimovitz-Friedman A, Vergilio JA, Nicholson AC (1993b) Macrophage and foam cell release of matrix-bound growth factors. Role of plasminogen activation. J Biol Chem 268:11951-11958
44. Fassing CH, Yingling JM, Howe DJ, Wang T, He WW, Gustafson ML, Shah P, Donahoe PK, Wang XF (1994) A transforming growth factor b type I receptor that signals to activate gene expression. Science 263:87-89
45. Feinberg MW, Jain MK (2005) Role of transforming growth factor-beta1/Smads in regulating vascular inflammation and atherogenesis. Panminerva Med 47:169-186
46. Feinberg MW, Watanabe M, Lebedeva MA, Depina AS, Hanai J, Mammoto T, Frederick JP, Wang XF, Sukhatme VP, Jain MK (2004) Transforming growth factor-beta1 inhibition of vascular smooth muscle cell activation is mediated via Smad3. J Biol Chem 279:16388-16393 (Pubitemid 38509335)
47. Flanders KC, Thompson NL, Cissel DS, Van Obberghen-Schilling E, Baker CC, Kass ME, Ellingsworth LR, Roberts AB, Sporn MB (1989) Transforming growth factor-b1: histochemical localization with antibodies to different epitopes. J Cell Biol 108:653-660 (Pubitemid 19065860)
48. Fleenor BS, Marshall KD, Durrant JR, Lesniewski LA, Seals DR (2010) Arterial stiffening with ageing is associated with transforming growth factor-beta1-related changes in adventitial collagen: reversal by aerobic exercise. J Physiol (Lond) 588:3971-3982
49. Franzen P, Dijke P, Ichijo H, Yamashita H, Schulz H, Heldin C-H, Miyazono K (1993) Cloning of a TGFb type I receptor that forms a heteromeric complex with the TGFb type II receptor. Cell 75:681-692
50. Frederick JP, Liberati NT, Waddell DS, Shi Y, Wang XF (2004) Transforming growth factor beta-mediated transcriptional repression of c-myc is dependent on direct binding of Smad3 to a novel repressive Smad binding element. Mol Cell Biol 24:2546-2559 (Pubitemid 38326008)
51. Frutkin AD, Otsuka G, Stempien-Otero A, Sesti C, Du L, Jaffe M, Dichek HL, Pennington CJ, Edwards DR, Nieves-Cintron M, Minter D, Preusch M, Hu JH, Marie JC, Dichek DA (2009) TGF-[beta]1 limits plaque growth, stabilizes plaque structure, and prevents aortic dilation in apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol 29:1251-1257
52. Fu K, Corbley MJ, Sun L, Friedman JE, Shan F, Papadatos JL, Costa D, Lutterodt F, Sweigard H, Bowes S, Choi M, Boriack-Sjodin PA, Arduini RM, Sun D, Newman MN, Zhang X, Mead JN, Chuaqui CE, Cheung HK, Cornebise M, Carter MB, Josiah S, Singh J, Lee WC, Gill A, Ling LE (2008) SM16, an orally active TGF-beta type I receptor inhibitor prevents myofibroblast induction and vascular fibrosis in the rat carotid injury model. Arterioscler Thromb Vasc Biol 28:665-671 (Pubitemid 351651335)
53. Fujii S, Hopkins WE, Sobel BE (1991) Mechanisms contributing to increased synthesis of plasminogen activator inhibitor type 1 in endothelial cells by constituents of platelets and their implications for thrombolysis. Circulation 83:645-651
54. Gabbiani G (2003) The myofibroblast in wound healing and fibrocontractive diseases. J Pathol 200:500-503
55. Gagarin D, Yang Z, Butler J, Wimmer M, Du B, Cahan P, McCaffrey TA (2005) Genomic profiling of acquired resistance to apoptosis in cells derived from human atherosclerotic lesions: potential role of STATs, cyclinD1, BAD, and Bcl-XL. J Mol Cell Cardiol 39:453-465 (Pubitemid 41133731)
56. Gojova A, Brun V, Esposito B, Cottrez F, Gourdy P, Ardouin P, Tedgui A, Mallat Z, Groux H (2003) Specific abrogation of transforming growth factor-beta signaling in T cells alters atherosclerotic lesion size and composition in mice. Blood 102:4052-4058 (Pubitemid 37486988)
57. Goumans MJ, Valdimarsdottir G, Itoh S, Rosendahl A, Sideras P, Dijke P ten (2002) Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors. EMBO J 21:1743-1753 (Pubitemid 34614630)
58. Grainger DJ (2004) Transforming growth factor beta and atherosclerosis: so far, so good for the protective cytokine hypothesis. Arterioscler Thromb Vasc Biol 24:399-404
59. Grainger DJ (2007) TGF-beta and atherosclerosis in man. Cardiovasc Res 74:213-222
60. Grainger DJ, Witchell CM, Watson JV, Metcalfe JC, Weissberg PL (1993) Heparin decreases the rate of proliferation of rat vascular smooth muscle cells by releasing transforming growth factor b-like activity from serum. Cardiovasc Res 27:2238-2247 (Pubitemid 24034740)
61. Grainger DJ, Kemp PR, Liu AC, Lawn RM, Metcalfe JC (1994) Activation of transforming growth factor-b is inhibited in transgenic apolipoprotein(a) mice. Nature 370:460-462 (Pubitemid 24263550)
62. Grainger DJ, Kemp PR, Metcalfe JC, Liu AC, Lawn RM, Williams NR, Grace AA, Schofield PM, Chauhan A (1995) The serum concentration of active transforming growth factor-b is severely depressed in advanced atherosclerosis. Nat Med 1:74-79
63. Gratchev A, Kzhyshkowska J, Kannookadan S, Ochsenreiter M, Popova A, Yu X, Mamidi S, Stonehouse-Usselmann E, Muller-Molinet I, Gooi L, Goerdt S (2008) Activation of a TGF-beta-specific multistep gene expression program in mature macrophages requires glucocorticoid-mediated surface expression of TGF-beta receptor II. J Immunol 180:6553-6565
64. Gressner OA, Lahme B, Siluschek M, Rehbein K, Weiskirchen R, Gressner AM (2009) Connective tissue growth factor is a Smad2 regulated amplifier of transforming growth factor beta actions in hepatocytes - but without modulating bone morphogenetic protein 7 signaling. Hepatology 49:2021-2030
65. Grotendorst GR (1997) Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts. Cytokine Growth Factor Rev 8:171-179
66. Harats D, George J, Levy Y, Khamashta MA, Hughes GR, Shoenfeld Y (1999) Atheroma: links with antiphospholipid antibodies, Hughes syndrome and lupus. QJM 92:57-59 (Pubitemid 29034101)
67. Hariri RJ, Alonso DR, Hajjar DP, Coletti D, Weksler ME (1986) Aging and atherosclerosis. I. Development of myointimal hyperplasia after endothelial injury. J Exp Med 164:1171-1178 (Pubitemid 16031614)
68. Hariri RJ, Hajjar DP, Coletti D, Alonso DR, Weksler ME, Rabellino E (1988) Aging and atherosclerosis. Cell cycle kinetics of young and old arterial smooth muscle cells. Am J Pathol 131:132-136
69. He F, Zhao D, Deng F, Zhong H, Shi X, Yang J, Guo S, Cheng J, Huang G, Tang B, Wang Z, Chen X, Wang G, Zhang W, Zhang C, Wang X, Hu Q (2010) Association of TGF-beta1 gene polymorphisms in exon1 and blood levels with essential hypertension. Blood Press 19:225-233
70. Heeg MH, Koziolek MJ, Vasko R, Schaefer L, Sharma K, Muller GA, Strutz F (2005) The antifibrotic effects of relaxin in human renal fibroblasts are mediated in part by inhibition of the Smad2 pathway. Kidney Int 68:96-109 (Pubitemid 43181367)
71. Heidland A, Sebekova K, Schinzel R (2001) Advanced glycation end products and the progressive course of renal disease. Am J Kidney Dis 38:S100-S106 (Pubitemid 32927622)
72. Heimark RL, Twardizik DR, Schwartz SM (1986) Inhibition of endothelial regeneration by type-b transforming growth factor from platelets. Science 233:1078-1080 (Pubitemid 16032237)
73. Hilker M, Langin T, Hake U, Schmid FX, Kuroczynski W, Lehr HA, Oelert H, Buerke M (2003) Gene expression profiling of human stenotic aorto-coronary bypass grafts by cDNA array analysis. Eur J Cardiothorac Surg 23:620-625 (Pubitemid 36411893)
74. Hogg N, Browning J, Howard T, Winterford C, Fitzpatrick D, Gobe G (1999) Apoptosis in vascular endothelial cells caused by serum deprivation, oxidative stress and transforming growth factor-beta. Endothelium 7:35-49 (Pubitemid 29481522)
75. Hyman KM, Seghezzi G, Pintucci G, Stellari G, Kim JH, Grossi EA, Galloway AC, Mignatti P (2002) Transforming growth factorbeta1 induces apoptosis in vascular endothelial cells by activation of mitogen-activated protein kinase. Surgery 132:173-179 (Pubitemid 35024758)
76. Ikedo H, Tamaki K, Ueda S, Kato S, Fujii M, Dijke P ten, Okuda S (2003) Smad protein and TGF-beta signaling in vascular smooth muscle cells. Int J Mol Med 11:645-650
77. Jager SC de, Bermudez B, Bot I, Koenen RR, Bot M, Kavelaars A, Waard V de, Heijnen CJ, Muriana FJ, Weber C, Berkel TJ van, Kuiper J, Lee SJ, Abia R, Biessen EA (2011) Growth differentiation factor 15 deficiency protects against atherosclerosis by attenuating CCR2-mediated macrophage chemotaxis. J Exp Med 208:217-225
78. Jeziorska M (2001) Transforming growth factor-betas and CD105 expression in calcification and bone formation in human atherosclerotic lesions. Z Kardiol 90 (Suppl 3):23-26
79. Jiang X, Zeng H, Guo Y, Zhou Z, Tang B, Li F (2004) The expression of matrix metalloproteinases-9, transforming growth factor beta1 and transforming growth factor-beta receptor I in human atherosclerotic plaque and their relationship with plaque stability. Chin Med J Engl 117:1825-1829 (Pubitemid 40074230)
80. Jones JA, Spinale FG, Ikonomidis JS (2009) Transforming growth factor-beta signaling in thoracic aortic aneurysm development: a paradox in pathogenesis. J Vasc Res 46:119-137
81. Joseph A, Ackerman D, Talley JD, Johnstone J, Kupersmith J (1993) Manifestations of coronary atherosclerosis in young trauma victims - an autopsy study. J Am Coll Cardiol 22:459-467 (Pubitemid 23214558)
82. Jung P, Menssen A, Mayr D, Hermeking H (2008) AP4 encodes a c-MYC-inducible repressor of p21. Proc Natl Acad Sci USA 105:15046-15051
83. Kanzaki T, Tamura K, Takahashi K, Saito Y, Akikusa B, Oohashi H, Kasayuki N, Ueda M, Morisaki N (1995) In vivo effect of TGFb1: enhanced intimal thickening by administration of TGF-b1 in rabbit arteries injured with a balloon catheter. Arterioscler Thromb 15:1951-1957
84. Keeton MR, Curriden SA, Zonneveld AJ van, Loskutoff DJ (1991) Identification of regulatory sequences in the type 1 plasminogen activator gene responsive to transforming growth factor beta. J Biol Chem 266:23048-23052 (Pubitemid 21908758)
85. Khan R, Agrotis A, Bobik A (2007) Understanding the role of transforming growth factor-beta1 in intimal thickening after vascular injury. Cardiovasc Res 74:223-234 (Pubitemid 46517511)
86. Kim GY, Mercer SE, Ewton DZ, Yan Z, Jin K, Friedman E (2002) The stress-activated protein kinases p38 alpha and JNK1 stabilize p21(Cip1) by phosphorylation. J Biol Chem 277:29792-29802
87. Kim JS, Kim JG, Moon MY, Jeon CY, Won HY, Kim HJ, Jeon YJ, Seo JY, Kim JI, Kim J, Lee JY, Kim PH, Park JB (2006) Transforming growth factor-beta1 regulates macrophage migration via RhoA. Blood 108:1821-1829 (Pubitemid 44394988)
88. Kletsas D, Stathakos D, Sorrentino V, Philipson L (1995) The growth-inhibitory block of TGF-beta is located close to the G1/S border in the cell cycle. Exp Cell Res 217:477-483
89. Knoflach M, Bernhard D, Wick G (2005) Anti-HSP60 immunity is already associated with atherosclerosis early in life. Ann NY Acad Sci 1051:323-331 (Pubitemid 41362762)
90. Kohn EA, Du Z, Sato M, Van Schyndle CM, Welsh MA, Yang YA, Stuelten CH, Tang B, Ju W, Bottinger EP, Wakefield LM (2010) A novel approach for the generation of genetically modified mammary epithelial cell cultures yields new insights into TGF-beta signaling in the mammary gland. Breast Cancer Res 12:R83
91. Kojima S, Nara K, Rifkin DB (1993) Requirement for transglutaminase in the activation of latent transforming growth factor-b in bovine endothelial cells. J Cell Biol 121:439-448 (Pubitemid 23110886)
92. Kolodgie FD, Narula J, Haider N, Virmani R (2001) Apoptosis in atherosclerosis. Does it contribute to plaque instability? Cardiol Clin 19:127-139 (Pubitemid 32433920)
93. Lawrence DA, Pircher R, Kryceve-Martineri C, Jullien P (1984) Normal embryo fibroblasts release transforming growth factors in a latent form. J Cell Physiol 121:184-188 (Pubitemid 14017248)
94. Le Scolan E, Zhu Q, Wang L, Bandyopadhyay A, Javelaud D, Mauviel A, Sun L, Luo K (2008) Transforming growth factor-beta suppresses the ability of Ski to inhibit tumor metastasis by inducing its degradation. Cancer Res 68:3277-3285
95. Lee J, Ko M, Joo CK (2008) Rho plays a key role in TGF-beta1-induced cytoskeletal rearrangement in human retinal pigment epithelium. J Cell Physiol 216:520-526 (Pubitemid 351898480)
96. Lin HY, Wang XF, Ng-Eaton E, Weinberg RA, Lodish HF (1992) Expression cloning of the TGF-b type II receptor, a functional transmembrane serine/threonine kinase. Cell 68:775-785
97. Liu X, Sun Y, Constantinescu SN, Karam E, Weinberg RA, Lodish HF (1997) Transforming growth factor beta-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells. Proc Natl Acad Sci USA 94:10669-10674
98. Liu X, Li P, Liu P, Xiong R, Zhang E, Chen X, Gu D, Zhao Y, Wang Z, Zhou Y (2008) The essential role for c-Ski in mediating TGF-beta1-induced bi-directional effects on skin fibroblast proliferation through a feedback loop. Biochem J 409:289-297
99. Lomo J, Blomhoff HK, Beiske K, Stokke T, Smeland EB (1995) TGFb1 and cyclic AMP promote apoptosis in resting human B lymphocytes. J Immunol 154:1634-1643
100. Lundberg V, Stegmayr B, Asplund K, Eliasson M, Huhtasaari F (1997) Diabetes as a risk factor for myocardial infarction: population and gender perspectives. J Intern Med 241:485-492 (Pubitemid 27315829)
101. Lutgens E, Gijbels M, Smook M, Heeringa P, Gotwals P, Koteliansky VE, Daemen MJ (2002) Transforming growth factor-beta mediates balance between inflammation and fibrosis during plaque progression. Arterioscler Thromb Vasc Biol 22:975-982 (Pubitemid 34655226)
102. Lyons RM, Keski-Oja J, Moses HL (1988) Proteolytic activation of latent transforming growth factor-b from fibroblast-conditioned medium. J Cell Biol 106:1659-1665
103. Lyons RM, Gentry LE, Purchio AF, Moses HL (1990) Mechanism of activation of latent recombinant transforming growth factor-b1 by plasmin. J Cell Biol 110:1361-1367
104. Machado RD, Aldred MA, James V, Harrison RE, Patel B, Schwalbe EC, Gruenig E, Janssen B, Koehler R, Seeger W, Eickelberg O, Olschewski H, Elliott CG, Glissmeyer E, Carlquist J, Kim M, Torbicki A, Fijalkowska A, Szewczyk G, Parma J, Abramowicz MJ, Galie N, Morisaki H, Kyotani S, Nakanishi N, Morisaki T, Humbert M, Simonneau G, Sitbon O, Soubrier F, Coulet F, Morrell NW, Trembath RC (2006) Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension. Hum Mutat 27:121-132 (Pubitemid 43238027)
105. Madri JA, Reidy MA, Kocher O, Bell L (1989) Endothelial cell behavior after denudation injury is modulated by transforming growth factor-b1 and fibronectin. Lab Invest 60:755-764
106. Majesky MW, Lindner V, Twardzik DR, Schwartz SM, Reidy MA (1991) Production of transforming growth factor-β1 during repair of arterial injury. J Clin Invest 88:904-910
107. Mallat Z, Gojova A, Marchiol-Fournigault C, Esposito B, Kamate C, Merval R, Fradelizi D, Tedgui A (2001) Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice. Circ Res 89:930-934 (Pubitemid 34627899)
108. Malmstrom J, Lindberg H, Lindberg C, Bratt C, Wieslander E, Delander EL, Sarnstrand B, Burns JS, Mose-Larsen P, Fey S, Marko-Varga G (2004) Transforming growth factor-beta 1 specifically induce proteins involved in the myofibroblast contractile apparatus. Mol Cell Proteomics 3:466-477 (Pubitemid 38714288)
109. Matsumoto Y, Uwatoku T, Oi K, Abe K, Hattori T, Morishige K, Eto Y, Fukumoto Y, Nakamura K, Shibata Y, Matsuda T, Takeshita A, Shimokawa H (2004) Long-term inhibition of Rho-kinase suppresses neointimal formation after stent implantation in porcine coronary arteries: involvement of multiple mechanisms. Arterioscler Thromb Vasc Biol 24:181-186 (Pubitemid 38082431)
110. McCaffrey TA, Falcone DJ (1993) Evidence for an age-related dysfunction in the antiproliferative response to transforming growth factor-beta in vascular smooth muscle cells. Mol Biol Cell 4:315-322 (Pubitemid 23119352)
111. McCaffrey TA, Nicholson AC, Szabo PE, Weksler ME, Weksler BB (1988) Aging and arteriosclerosis. The increased proliferation of arterial smooth muscle cells isolated from old rats is associated with increased platelet-derived growth factor-like activity. J Exp Med 167:163-174 (Pubitemid 18093700)
112. McCaffrey TA, Falcone DJ, Brayton CF, Agarwal LA, Welt FG, Weksler BB (1989) Transforming growth factor-beta activity is potentiated by heparin via dissociation of the transforming growth factor-beta/alpha 2-macroglobulin inactive complex. J Cell Biol 109:441-448 (Pubitemid 19180150)
113. McCaffrey TA, Falcone DJ, Du B (1992) Transforming growth factor-beta 1 is a heparin-binding protein: identification of putative heparin-binding regions and isolation of heparins with varying affinity for TGF-beta 1. J Cell Physiol 152:430-440
114. McCaffrey TA, Consigli S, Du B, Falcone DJ, Sanborn TA, Spokojny AM, Bush HL Jr (1995) Decreased type II/type I TGF-beta receptor ratio in cells derived from human atherosclerotic lesions. Conversion from an antiproliferative to profibrotic response to TGF-beta1. J Clin Invest 96:2667-2675
115. McCaffrey TA, Du B, Consigli S, Szabo P, Bray PJ, Hartner L, Weksler BB, Sanborn TA, Bergman G, Bush HL Jr (1997) Genomic instability in the type II TGF-beta1 receptor gene in atherosclerotic and restenotic vascular cells. J Clin Invest 100:2182-2188 (Pubitemid 27500139)
116. McCaffrey TA, Du B, Fu C, Bray PJ, Sanborn TA, Deutsch E, Tarazona N, Shaknovitch A, Newman G, Patterson C, Bush HL Jr (1999) The expression of TGF-beta receptors in human atherosclerosis: evidence for acquired resistance to apoptosis due to receptor imbalance. J Mol Cell Cardiol 31:1627-1642 (Pubitemid 29414583)
117. Mehta VY, Jorgensen MB, Raizner AE, Wolde-Tsadik G, Mahrer PR, Mansukhani P (1995) Spontaneous regression of restenosis: an angiographic study. J Am Coll Cardiol 26:696-702
118. Meine TJ, Bauman RP, Yock PG, Rembert JC, Greenfield JC Jr (1999) Coronary artery restenosis after atherectomy is primarily due to negative remodeling. Am J Cardiol 84:141-146 (Pubitemid 29331328)
119. Merideth MA, Gordon LB, Clauss S, Sachdev V, Smith AC, Perry MB, Brewer CC, Zalewski C, Kim HJ, Solomon B, Brooks BP, Gerber LH, Turner ML, Domingo DL, Hart TC, Graf J, Reynolds JC, Gropman A, Yanovski JA, Gerhard-Herman M, Collins FS, Nabel EG, Cannon RO 3rd, Gahl WA, Introne WJ (2008) Phenotype and course of Hutchinson-Gilford progeria syndrome. N Engl J Med 358:592-604 (Pubitemid 351214286)
120. Mintz GS, Pichard AD, Kent KM, Satler LF, Popma JJ, Leon MB (1998) Interrelation of coronary angiographic reference lumen size and intravascular ultrasound target lesion calcium. Am J Cardiol 81:387-391 (Pubitemid 28099525)
121. Miura M, Hata Y, Hirayama K, Kita T, Noda Y, Fujisawa K, Shimokawa H, Ishibashi T (2006) Critical role of the Rho-kinase pathway in TGF-beta2-dependent collagen gel contraction by retinal pigment epithelial cells. Exp Eye Res 82:849-859 (Pubitemid 43170885)
122. Mooradian DL, Lucas RC, Weatherbee JA, Furcht LT (1989) Transforming growth factor-b1 binds to immobilized fibronectin. J Cell Biochem 41:189-200 (Pubitemid 20026036)
123. Murphy-Ullrich JE, Schultz-Cherry S, Hook M (1992) Transforming growth factor-b complexes with thrombospondin. Mol Biol Cell 3:181-188 (Pubitemid 23084549)
124. Nabel EG, Shum L, Pompili VJ, Yang Z-Y, San H, Shu HB, Liptay S, Gold L, Gordon D, Derynck R, Nabel GJ (1993) Direct transfer of transforming growth factor b1 gene into arteries stimulates fibrocellular hyperplasia. Proc Natl Acad Sci USA 90:10759-10763 (Pubitemid 23347122)
125. Nagata H, Hatano E, Tada M, Murata M, Kitamura K, Asechi H, Narita M, Yanagida A, Tamaki N, Yagi S, Ikai I, Matsuzaki K, Uemoto S (2009) Inhibition of c-Jun NH2-terminal kinase switches Smad3 signaling from oncogenesis to tumor- suppression in rat hepatocellular carcinoma. Hepatology 49:1944-1953
126. Nakashima Y, Fujii H, Sumiyoshi S, Wight TN, Sueishi K (2007) Early human atherosclerosis: accumulation of lipid and proteoglycans in intimal thickenings followed bymacrophage infiltration.Arterioscler Thromb Vasc Biol 27:1159-1165 (Pubitemid 46641972)
127. Nikol S, Isner JM, Pickering JG, Kearney M, Leclerc G, Weir L (1992) Expression of transforming growth factor-b1 is increased in human vascular restenosis lesions. J Clin Invest 90:1582-1592
128. Otsuka G, Agah R, Frutkin AD, Wight TN, Dichek DA (2006) Transforming growth factor beta 1 induces neointima formation through plasminogen activator inhibitor-1-dependent pathways. Arterioscler Thromb Vasc Biol 26:737-743 (Pubitemid 43732145)
129. Paralkar VM, Vukicevic S, Reddi AH (1991) Transforming growth factor-b type 1 binds to collagen IV of basement membrane matrix: implications for development. Dev Biol 143:303-308 (Pubitemid 121004656)
130. Pardali K, Kurisaki A, Moren A, Dijke P ten, Kardassis D, Moustakas A (2000) Role of Smad proteins and transcription factor Sp1 in p21(Waf1/Cip1) regulation by transforming growth factor-beta. J Biol Chem 275:29244-29256 (Pubitemid 32043793)
131. Pardali K, Kowanetz M, Heldin CH, Moustakas A (2005) Smad pathway-specific transcriptional regulation of the cell cycle inhibitor p21(WAF1/Cip1). J Cell Physiol 204:260-272 (Pubitemid 40776829)
132. Pepper MS, Vassalli J-D, Orci L, Montesano R (1993) Biphasic effect of transforming growth factor-b1 on in vitro angiogenesis. Exp Cell Res 204:356-363 (Pubitemid 23200200)
133. Perros F, Dorfmuller P, Humbert M (2005) Current insights on the pathogenesis of pulmonary arterial hypertension. Semin Respir Crit Care Med 26:355-364 (Pubitemid 41266491)
134. Pierelli L, Marone M, Bonanno G, Mozzetti S, Rutella S, Morosetti R, Rumi C, Mancuso S, Leone G, Scambia G (2000) Modulation of bcl-2 and p27 in human primitive proliferating hematopoietic progenitors by autocrine TGF-beta1 is a cell cycle-independent effect and influences their hematopoietic potential. Blood 95:3001-3009
135. Pollman M, Naumovski L, Gibbons G (1999) Vascular cell apoptosis: cell type-specific modulation by transforming growth factor-β1 in endothelial cells versus smooth muscle cells. Circulation 99:2019-2026 (Pubitemid 29183900)
136. Redondo S, Ruiz E, Padilla E, Gordillo-Moscoso A, Tejerina T (2007) Role of TGF-beta1 in vascular smooth muscle cell apoptosis induced by angiotensin II. Eur J Pharmacol 556:36-44 (Pubitemid 46074003)
137. Rembold C (1996) Could atherosclerosis originate from defective smooth muscle cell death? Perspect Biol Med 39:405-408
138. Rich JN, Zhang M, Datto MB, Bigner DD, Wang XF (1999) Transforming growth factor-beta-mediated p15(INK4B) induction and growth inhibition in astrocytes is SMAD3-dependent and a pathway prominently altered in human glioma cell lines. J Biol Chem 274:35053-35058 (Pubitemid 129509557)
139. Rivera P, Ocaranza MP, Lavandero S, Jalil JE (2007) Rho kinase activation and gene expression related to vascular remodeling in normotensive rats with high angiotensin I converting enzyme levels. Hypertension 50:792-798 (Pubitemid 47442747)
140. Robertson AK, Rudling M, Zhou X, Gorelik L, Flavell RA, Hansson GK (2003) Disruption of TGF-beta signaling in T cells accelerates atherosclerosis. J Clin Invest 112:1342-1350 (Pubitemid 38057688)
141. Rocha VZ, Libby P (2009) Obesity, inflammation, and atherosclerosis. Nat Rev Cardiol 6:399-409
142. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, Carnethon MR, Dai S, Simone G de, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Greenlund KJ, Hailpern SM, Heit JA, Ho PM, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, McDermott MM, Meigs JB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Rosamond WD, Sorlie PD, Stafford RS, Turan TN, Turner MB, Wong ND, Wylie-Rosett J (2011) Heart disease and stroke statistics - 2011 update: a report from the American Heart Association. Circulation 123:e18-e209
143. Rook GA (2001) The TGF-beta1 paradox in asthma. Trends Immunol 22:299-300
144. Ross R (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362:801-809
145. Ross R, Masuda J, Raines EW, Gown AM, Katsuda S, Sasahara M, Malden LT, Masuko H, Sato H (1990) Localization of PDGF-B protein in macrophages in all stages of atherogenesis. Science 248:1009-1012
146. Rossi P, Karsenty G, Roberts A, Roche NS, Sporn MB, Crombrugghe B (1988) A nuclear factor-1 binding site mediates the transcriptional activation of a type I collagen promoter by transforming growth factor-b. Cell 52:405-414 (Pubitemid 18057397)
147. Sachdeva A, Cannon CP, Deedwania PC, Labresh KA, Smith SC Jr, Dai D, Hernandez A, Fonarow GC (2009) Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get With The Guidelines. Am Heart J 157:e112
148. Saltis J, Agrotis A, Kanellakis P, Bobik A (1994) Developmentally regulated transforming growth factor-beta 1 action on vascular smooth muscle growth in the SHR. Clin Exp Pharmacol Physiol 21:149-152 (Pubitemid 24141730)
149. Saltis J, Agrotis A, Bobik A (1996) Regulation and interactions of transforming growth factor-beta with cardiovascular cells: implications for development and disease. Clin Exp Pharmacol Physiol 23:193-200 (Pubitemid 26167427)
150. Samarakoon R, Higgins PJ (2008) Integration of non-SMAD and SMAD signaling in TGF-beta1-induced plasminogen activator inhibitor type-1 gene expression in vascular smooth muscle cells. Thromb Haemost 100:976-983
151. Sarzani R, Brecher P, Chobanian AV (1989) Growth factor expression in aorta of normotensive and hypertensive rats. J Clin Invest 83:1404-1408 (Pubitemid 19113058)
152. Schmitt-Graff A, Desmouliere A, Gabbiani G (1994) Heterogeneity of myofibroblast phenotypic features: an example of fibroblastic cell plasticity. Virchows Arch 425:3-24 (Pubitemid 24295501)
153. Schultz-Cherry S, Lawler J, Murphy-Ullrich JE (1994) The type 1 repeats of thrombospondin 1 activate latent transforming growth factor-b. J Biol Chem 269:26783-26788 (Pubitemid 24332872)
154. Scott L, Kerr A, Haydock D, Merrilees M (1997) Subendothelial proteoglycan synthesis and transforming growth factor beta distribution correlate with susceptibility to atherosclerosis. J Vasc Res 34:365-377 (Pubitemid 27414506)
155. Seay U, Sedding D, Krick S, Hecker M, Seeger W, Eickelberg O (2005) Transforming growth factor-beta-dependent growth inhibition in primary vascular smooth muscle cells is p38-dependent. J Pharmacol Exp Ther 315:1005-1012 (Pubitemid 41635386)
156. Shen X, Li J, Hu PP, Waddell D, Zhang J, Wang XF (2001) The activity of guanine exchange factor NET1 is essential for transforming growth factor-beta-mediated stress fiber formation. J Biol Chem 276:15362-15368
157. Shimada H, Staten NR, Rajagopalan LE (2011) TGF-beta1 mediated activation of Rho kinase induces TGF-beta2 and endothelin-1 expression in human hepatic stellate cells. J Hepatol 54:521-528
158. Simionescu A, Philips K, Vyavahare N (2005) Elastin-derived peptides and TGF-beta1 induce osteogenic responses in smooth muscle cells. Biochem Biophys Res Commun 334:524-532 (Pubitemid 40982398)
159. Simper D, Stalboerger PG, Panetta CJ, Wang S, Caplice NM (2002) Smooth muscle progenitor cells in human blood. Circulation 106:1199-1204 (Pubitemid 34988636)
160. Sinha S, Hoofnagle MH, Kingston PA, McCanna ME, Owens GK (2004) Transforming growth factor-beta1 signaling contributes to development of smooth muscle cells from embryonic stem cells. Am J Physiol Cell Physiol 287:C1560-C1568 (Pubitemid 39507673)
161. Sinha S, Hoofnagle MH, Owens GK (2009) Derivation of contractile smooth muscle cells from embryonic stem cells. Methods Mol Biol 482:345-367
162. Smith PC, Caceres M, Martinez J (2006) Induction of the myofibroblastic phenotype in human gingival fibroblasts by transforming growth factor-beta1: role of RhoA-ROCK and c-Jun N-terminal kinase signaling pathways. J Periodontal Res 41:418-425 (Pubitemid 44337257)
163. Sorrentino A, Thakur N, Grimsby S, Marcusson A, Bulow V von, Schuster N, Zhang S, Heldin CH, Landstrom M (2008) The type I TGF-beta receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner. Nat Cell Biol 10:1199-1207
164. Spender LC, Inman GJ (2009) TGF-beta induces growth arrest in Burkitt lymphoma cells via transcriptional repression of E2F-1. J Biol Chem 284:1435-1442
165. Stefoni S, Cianciolo G, Donati G, Dormi A, Silvestri MG, Coli L, De Pascalis A, Iannelli S (2002) Low TGF-beta1 serum levels are a risk factor for atherosclerosis disease in ESRD patients. Kidney Int 61:324-335 (Pubitemid 34075160)
166. Stemerman MB, Weinstein R, Rowe JW, Maciag T, Fuhro R, Gardner R (1982) Vascular smooth muscle cell growth kinetics in vivo in aged rats. Proc Natl Acad Sci USA 79:3863-3866 (Pubitemid 12013558)
167. Strong J (1993) Natural history of aortic and coronary atherosclerotic lesions in youth. Findings from the PDAY Study. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Arterioscler Thromb 13:1291-1298
168. Strong JP (1995) Natural history and risk factors for early human atherogenesis. Pathobiological Determinants in Youth (PDAY) Research Group. Clin Chem 41:134-138
169. Suwanabol PA, Kent KC, Liu B (2011) TGF-beta and restenosis revisited: a Smad link. J Surg Res 167:287-297
170. Suzuki H, Yagi K, Kondo M, Kato M, Miyazono K, Miyazawa K (2004) c-Ski inhibits the TGF-beta signaling pathway through stabilization of inactive Smad complexes on Smad-binding elements. Oncogene 23:5068-5076 (Pubitemid 38938740)
171. Takahata M, Inoue Y, Tsuda H, Imoto I, Koinuma D, Hayashi M, Ichikura T, Yamori T, Nagasaki K, Yoshida M, Matsuoka M, Morishita K, Yuki K, Hanyu A, Miyazawa K, Inazawa J, Miyazono K, Imamura T (2009) SKI and MEL1 cooperate to inhibit transforming growth factor-beta signal in gastric cancer cells. J Biol Chem 284:3334-3344
172. Tashiro H, Shimokawa H, Sadamatu K, Yamamoto K (2002) Prognostic significance of plasma concentrations of transforming growth factor-beta in patients with coronary artery disease. Coron Artery Dis 13:139-143 (Pubitemid 34747960)
173. Tesseur I, Zhang H, Brecht W, Corn J, Gong JS, Yanagisawa K, Michikawa M, Weisgraber K, Huang Y, Wyss-Coray T (2009) Bioactive TGF-beta can associate with lipoproteins and is enriched in those containing apolipoprotein E3. J Neurochem 110:1254-1262
174. Tian M, Schiemann WP (2009) The TGF-beta paradox in human cancer: an update. Future Oncol 5:259-271
175. Topouzis S, Majesky MW (1996) Smooth muscle lineage diversity in the chick embryo. Two types of aortic smooth muscle cell differ in growth and receptor-mediated transcriptional responses to transforming growth factor-beta. Dev Biol 178:430-445 (Pubitemid 26365049)
176. Tsai S, Hollenbeck ST, Ryer EJ, Edlin R, Yamanouchi D, Kundi R, Wang C, Liu B, Kent KC (2009) TGF-{beta} through Smad3 signaling stimulates vascular smooth muscle cell proliferation and neointimal formation. Am J Physiol Heart Circ Physiol 297:H540-H549
177. Tsunawaki S, Sporn M, Ding A, Nathan C (1988) Deactivation of macrophages by transforming growth factor-beta. Nature 334:260-262
178. Upton PD, Morrell NW (2009) TGF-beta and BMPR-II pharmacology - implications for pulmonary vascular diseases. Curr Opin Pharmacol 9:274-280
179. Vaudo G, Bocci EB, Shoenfeld Y, Schillaci G, Wu R, Del Papa N, Vitali C, Delle Monache F, Marchesi S, Mannarino E, Gerli R (2005) Precocious intima-media thickening in patients with primary Sjogren's syndrome. Arthritis Rheum 52:3890-3897 (Pubitemid 41798228)
180. Vihert A (1976) Atherosclerosis of the aorta and coronary arteries in five towns. Bull World Health Organ 53:501-614
181. Villines TC, Stanek EJ, Devine PJ, Turco M, Miller M, Weissman NJ, Griffen L, Taylor AJ (2010) The ARBITER 6-HALTS Trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 6-HDL and LDL Treatment Strategies in Atherosclerosis): final results and the impact of medication adherence, dose, and treatment duration. J Am Coll Cardiol 55:2721-2726
182. Vranken I, De Visscher G, Lebacq A, Verbeken E, Flameng W (2008) The recruitment of primitive Lin(-) Sca-1(+), CD34(+), c-kit(+) and CD271(+) cells during the early intraperitoneal foreign body reaction. Biomaterials 29:797-808 (Pubitemid 350278533)
183. Wakefield LM, Letterio JJ, Chen T, Danielpour D, Allison RS, Pai LH, Denicoff AM, Noone MH, Cowan KH, O'Shaughnessy JA et al (1995) Transforming growth factor-beta1 circulates in normal human plasma and is unchanged in advanced metastatic breast cancer. Clin Cancer Res 1:129-136
184. Wan Y, Liu X, Kirschner MW (2001) The anaphase-promoting complex mediates TGF-beta signaling by targeting SnoN for destruction. Mol Cell 8:1027-1039 (Pubitemid 34031805)
185. Wang B, Omar A, Angelovska T, Drobic V, Rattan SG, Jones SC, Dixon IM (2007) Regulation of collagen synthesis by inhibitory Smad7 in cardiac myofibroblasts. Am J Physiol Heart Circ Physiol 293:H1282-H1290 (Pubitemid 47254231)
186. Wang N, Wang X, Xing C, Sun B, Yu X, Hu J, Liu J, Zeng M, Xiong M, Zhou S, Yang J (2010) Role of TGF-beta1 in bone matrix production in vascular smooth muscle cells induced by a high-phosphate environment. Nephron Exp Nephrol 115:e60-e68
187. Weitzman S, Wang C, Rosamond WD, Chambless LE, Cooper LS, Shahar E, Goff DC (2004) Is diabetes an independent risk factor for mortality after myocardial infarction? The ARIC (Atherosclerosis Risk in Communities) Surveillance Study. Acta Diabetol 41:77-83 (Pubitemid 38849831)
188. Wen FQ, Kohyama T, Skold CM, Zhu YK, Liu X, Romberger DJ, Stoner J, Rennard SI (2002) Glucocorticoids modulate TGF-beta production. Inflammation 26:279-290
189. Wolf YG, Rasmussen LM, Ruoslahti E (1994) Antibodies against transforming growth factor-β1 suppress intimal hyperplasia in a rat model. J Clin Invest 93:1172-1178 (Pubitemid 24087172)
190. Wrana JL, Attisano L, Carcamo J, Zentella A, Doody J, Laiho M, Wang XF, Massague J (1992) TGF beta signals through a heteromeric protein kinase receptor complex. Cell 71:1003-1014
191. Wrana JL, Attisano L, Wieser R, Ventura F, Massague J (1994) Mechanism of activation of the TGF-b receptor. Nature 370:341-347
192. Xu A, Kochanek K, Murphy S (2010) Deaths: final data for 2007. Natl Vital Statistics Reports 58:1-135
193. Xu W, Angelis K, Danielpour D, Haddad MM, Bischof O, Campisi J, Stavnezer E, Medrano EE (2000) Ski acts as a co-repressor with Smad2 and Smad3 to regulate the response to type beta transforming growth factor. Proc Natl Acad Sci USA 97:5924-5929 (Pubitemid 30367500)
194. Yagi K, Furuhashi M, Aoki H, Goto D, Kuwano H, Sugamura K, Miyazono K, Kato M (2002) c-myc is a downstream target of the Smad pathway. J Biol Chem 277:854-861 (Pubitemid 34952127)
195. Yamaguchi Y, Mann DM, Ruoslahti E (1990) Negative regulation of transforming growth factor-b by the proteoglycan decorin. Nature 346:281-284
196. Yamashita M, Fatyol K, Jin C, Wang X, Liu Z, Zhang YE (2008) TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-beta. Mol Cell 31:918-924
197. Yang Z, Gagarin D, Ramezani A, Hawley RG, McCaffrey TA (2007) Resistance to fas-induced apoptosis in cells from human atherosclerotic lesions: elevated Bcl-XL inhibits apoptosis and caspase activation. J Vasc Res 44:483-494 (Pubitemid 350022322)
198. Yokote K, Kobayashi K, Saito Y (2006) The role of Smad3-dependent TGF-beta signal in vascular response to injury. Trends Cardiovasc Med 16:240-245 (Pubitemid 44374368)
199. Yuzawa H, Koinuma D, Maeda S, Yamamoto K, Miyazawa K, Imamura T (2009) Arkadia represses the expression of myoblast differentiation markers through degradation of Ski and the Ski-bound Smad complex in C2C12 myoblasts. Bone 44:53-60
200. Zeller KI, Jegga AG, Aronow BJ, O'Donnell KA, Dang CV (2003) An integrated database of genes responsive to the Myc oncogenic transcription factor: identification of direct genomic targets. Genome Biol 4:R69
201. Zhang YE (2009) Non-Smad pathways in TGF-beta signaling. Cell Res 19:128-139
202. Zhou MS, Schuman IH, Jaimes EA, Raij L (2008) Renoprotection by statins is linked to a decrease in renal oxidative stress, TGF-beta, and fibronectin with concomitant increase in nitric oxide bioavailability. Am J Physiol Renal Physiol 295:F53-F59
203. Zhou X, Johnston TP, Johansson D, Parini P, Funa K, Svensson J, Hansson GK (2009) Hypercholesterolemia leads to elevated TGF-beta1 activity and T helper 3-dependent autoimmune responses in atherosclerotic mice. Atherosclerosis 204:381-387
204. Zohlnhofer D, Richter T, Neumann F, Nuhrenberg T, Wessely R, Brandl R, Murr A, Klein C, Baeuerle P (2001) Transcriptome analysis reveals a role of interferon-g in human neointima formation. Mol Cell 7:1059-1069 (Pubitemid 32525752)